Tick Tock: Inside Pfizer’s Bid to Vaccinate Against Lyme
did:plc:yhmwewfk3g3hhkrw2gf4ypna
March 30, 2026
Pfizer & Valneva plan a 2026 Lyme vaccine. Protein-based and four-dose, it raises questions about safety, transparency, and public trust.
Discussion in the ATmosphere